Midaxifylline
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161546This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C16H25N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A937Z0MS6C, chemically known as 8-(1-aminocyclopentyl)-1,3-dipropylxanthine but generally known as midaxifylline, which bears US NIH Compound Identifier 3047747. European Medicines Agency schedules Midaxifylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03288MIG. The term MIDAXIFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 1, 1999, List 41). Most nations schedule midaxifylline under HS 29395900 and SITC 54145. As of Q4 2014, MIDAXIFYLLINE remains the US FDA Preferred Term for this commodity. Midaxifylline bears US NLM identifiers UMLS ID C1881825 and NCI Concept Code C66147. SMILES: O=C1N(C(=O)N(C2NC([NH]C12)C1(N)CCCC1)CCC)CCC.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.